Pfizer Lilly: Different Bets on Pharma M&A Explained
Eli Lilly posts a blockbuster start to 2026 as Pfizer works to rebuild after the COVID era, highlighting pfizer lilly...
We compare which high yield ETF is tax efficient for retirement, highlighting tax considerations, holdings, and strategies to maximize after-tax income.
27,106 articlesEli Lilly posts a blockbuster start to 2026 as Pfizer works to rebuild after the COVID era, highlighting pfizer lilly...
A large fund sold a sizable stake, and the stock still lagged the market. This look breaks down what happened, why it...
April data show 7.6 million job openings, up from March as hiring slows and layoffs drop. The report highlights a sti...
Oracle confronts a fresh wave of investor anxiety as a heavy OpenAI backlog, negative cash flow, and mounting leverag...
Adobe has faced a significant stock drop, but a lower price isn’t the same as a bargain. This guide breaks down what ...
Greg Abel, the man tapped to carry on Warren Buffett's investing legacy, is making a bold AI move with Alphabet. Berk...
A surprise performance of Avril Lavigne’s “Sk8er Boi” at a high-profile wedding became more than nostalgia — it highl...
Cava's yearly revenue just crossed the $1 billion mark, signaling a major milestone for the fast-casual chain. This a...
Regulators signal a softer approach while a Trump-linked venture secures $75 million from Justin Sun, fueling specula...
A private AI company is offering under-$1 pre-IPO shares to everyday investors as it targets a Nasdaq debut later thi...
A California family filed a wrongful-death lawsuit against OpenAI, claiming ChatGPT guidance led to a teen's fatal ov...
A high-flying biotech spin-off has faced a brutal disconnect between hype and reality. This beaten-down growth stock ...